In January, the FDA released the second revision of the Draft Guidance, “Current Good Manufacturing Practice—Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act.”      The Agency initially submitted the Draft Guidance in 2014 and followed up with Revision One in December 2018.      Currently, GMPs for drug